Y-mAbs Therapeutics Inc. (YMAB)
5.20
-0.36 (-6.47%)
At close: Mar 03, 2025, 3:59 PM
5.15
-0.85%
After-hours: Mar 03, 2025, 06:41 PM EST
Y-mAbs Therapeutics Revenue
Y-mAbs Therapeutics reported an annual revenue of $84.82M, reflecting a 29.96% growth. For the quarter ending September 30, 2024, Y-mAbs Therapeutics generated $18.46M in revenue.
Revenue (ttm)
$84.82M
Revenue Growth
29.96%
Price / Sales Ratio
3.51
Revenue / Employee
$848.19K
Employees
100
Market Cap
232.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 84.82M | +29.96% |
| Dec 31, 2022 | 65.27M | +87.03% |
| Dec 31, 2021 | 34.9M | +68.18% |
| Dec 31, 2020 | 20.75M | n/a |